Current price is less than the intrinsic value
Insufficient Data
Stock doesn't offer attractive dividend returns
Good time to consider, as stock is not in overbought zone
Stock not in ASM/GSM lists and not a lot of promoter holding is pledged
—
—
—
Global Longlife Hospital and Research Limited is a multispecialty hospital operator. The Company's medical services include oncology, ophthalmology, allergy & immunology, pain management, pulmonology, anesthesiology, cardiology, dermatology, critical care, diabetes & endocrinology, GI medicine, gynecology, infectious disease, nephrology and neurology. Its surgical services include CVTS, joint replacement & ortho, general surgery, onco surgery, GI surgery, neurosurgery and ear, nose and throat (ENT). Its radiology services include mammography, CT scan, X-ray, ultrasound, endoscopy, sonography, and others. Its pathology services include microbiology, biochemistry, clinical pathology, cyto pathology, hematology, serology, and others. Its other services include dialysis, pharmacy, ambulance, dietary and physiotherapy.
Customise key metrics, see detailed forecasts, download stock data and more
In last 6 months, promoter holding in the company has decreased by 9.46%
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
Intrinsic valueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Current price is less than the intrinsic value